Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Clark

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
Journal of Health Communication|February 6, 2004
Preventing domestic violence in the african american community: assessing the impact of a dramatic radio serialRicardo J Wray, Robert M Hornik, Oscar H Gandy, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|May 26, 2015
Transvaginal morcellationLindsay Clark Donat, Mitchell Clark, Amanda M Tower, et al.
Gynecologic Oncology|July 30, 2021
Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic reviewCaitlin Lazurko, Mitchell Clark, Kate Pulman, et al.
Gynecologic Oncology|December 13, 2023
Black-White differences in uterine cancer symptomatology and stage at diagnosisXiao Xu, Ling Chen, Marcella Nunez-Smith, et al.
Gynecologic Oncology|October 3, 2024
Diagnostic experiences of Black and White patients with uterine cancer: A qualitative studyMeredith Campbell Britton, Elizabeth Izampuye, Mitchell Clark, et al.
Gynecologic Oncology|October 30, 2025
Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancerXiao Xu, Ling Chen, Marcella Nunez-Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine CancerAlessandro D Santin, Dana M Roque, Eric Siegel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2026
Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort studyYasmin Abozenah, Hadi Erfani, Carolyn Haunschild, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
Journal of Health Communication|February 6, 2004
Preventing domestic violence in the african american community: assessing the impact of a dramatic radio serialRicardo J Wray, Robert M Hornik, Oscar H Gandy, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|May 26, 2015
Transvaginal morcellationLindsay Clark Donat, Mitchell Clark, Amanda M Tower, et al.
Gynecologic Oncology|July 30, 2021
Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic reviewCaitlin Lazurko, Mitchell Clark, Kate Pulman, et al.
Gynecologic Oncology|December 13, 2023
Black-White differences in uterine cancer symptomatology and stage at diagnosisXiao Xu, Ling Chen, Marcella Nunez-Smith, et al.
Gynecologic Oncology|October 3, 2024
Diagnostic experiences of Black and White patients with uterine cancer: A qualitative studyMeredith Campbell Britton, Elizabeth Izampuye, Mitchell Clark, et al.
Gynecologic Oncology|October 30, 2025
Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancerXiao Xu, Ling Chen, Marcella Nunez-Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine CancerAlessandro D Santin, Dana M Roque, Eric Siegel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2026
Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort studyYasmin Abozenah, Hadi Erfani, Carolyn Haunschild, et al.
Pageof 6